FDA/CDC

FDA queries more companies about youth e-cig use


 

Four more e-cigarette manufacturers are facing Food and Drug Administration scrutiny in an effort for the agency to better understand youth appeal and usage of e-cigarettes.

“Too many kids continue to experiment with e-cigarette and vaping products, putting them at risk for developing a lifelong nicotine addiction,” FDA Commissioner Scott Gottlieb, MD, said in a statement. “These products should never be marketed to, sold to, or used by kids, and it’s critical that we take aggressive steps to address the youth use of these products.”

ecigarette teenager Thinkstockphotos.com
The agency sent letters May 17 to four manufacturers: J Well; YGT Investment and 7 Daze; Liquid Filling Solutions; and SRV. This latest round of inquiries follows a similar request for information letter sent April 24 to JUUL Labs.

The agency is seeking information including, but not limited to, “documents related to product marketing, documents related to research on product design (as it may relate to the appeal or addictive potential for youth, youth-related adverse experiences), and consumer complaints associated with products,” the agency said in a statement.

The May 17 letters note that the four companies manufacture products similar to JUUL’s product offering, sharing similar characteristics, “including e-liquids that contain nicotine salts with corresponding high nicotine concentration, small size which makes them easily concealable, and product design features that are intuitive, even for novice [electronic nicotine delivery system] users. These attributes may relate to the appeal and addictiveness of the product, particularly for youth who may be experimenting with tobacco products.”

The action is the latest in the agency’s effort to combat nicotine addiction. In March, the agency issues an advanced notice of proposed rule making seeking information on the role flavoring plays in youth tobacco consumption.

Recommended Reading

CDC: Marijuana use may spur industries to rethink current policies
MDedge Psychiatry
MDedge Daily News: Where doctors stand on Medicaid work requirements
MDedge Psychiatry
MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Psychiatry
Don’t use cannabis to treat OSA, AASM recommends
MDedge Psychiatry
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Psychiatry
MDedge Daily News: Physician burnout needs more than yoga
MDedge Psychiatry
Stroke patients benefited from CPAP
MDedge Psychiatry
MDedge Daily News: Lupus is quietly killing young women
MDedge Psychiatry
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Psychiatry
E-cigarette usage has changed
MDedge Psychiatry